Different types of leukemia and stem cell transplantation have been treated by blocking the function of CD45 with specific antibodies or inhibitors (Ostergaard and Trowbridge, 1991; Autero et al., 1994; Hermiston et al., 2003). The gene discussed is PTPRC; the disease is leukemia.